14158 Federal Register / Vol. 62, No. 57 / Tuesday, March 25, 1997 / Notices

Dated: March 18, 1997.

Sheila E. Merritt,

Executive Officer, National Heart, Lung, and

Blood Institute.

[FR Doc. 97–7376 Filed 3–24–97; 8:45 am]

BILLING CODE 4140–01–M

Submission for OMB Review;

Comment Request NIH Intramural

Research Training Award, Program

Application

SUMMARY: Under the provisions of

Section 3506(c)(2)(A) of the Paperwork

Reduction Act of 1995, the Office of the

Director, the National Institutes of

Health (NIH) has submitted to the Office

of Management and Budget (OMB) a

request to review and approve the

information collection listed below.

This proposed information collection

was previously published in the Federal

Register on January 10, 1997, pages

1463–1464 and allowed 60 days for

public comment. No public comments

were received. The purpose of this

notice is to allow an additional 30 days

for public comment. The National

Institutes of Health may not conduct or

sponsor, and the respondent is not

required to respond to an information

collection that has been extended,

revised, or implemented on or after

October 1, 1995, unless it displays a

currently valid OMB control number.

PROPOSED COLLECTION: Title: NIH

Intramural Research Training Award,

Program Application. Type of

Information Collection Request:

Revision of OMB No. 0925–0299; 4/30/

97. Need and Use of Information

Collection: The proposed information

collection activity is for the purpose of

collecting date related to the availability

of training fellowships under the NIH

Intramural Research Training Award

Program. This information must be

submitted in order to receive due

consideration for an award and will be

used to determine the eligibility and

quality of potential awardees.

Frequency of Response: On occasion.

Affected Public: Individuals or

households. Type of Respondents:

Postdoctoral, Predoctoral,

Supplemental, Technical, Summer, and

Student Support IRTA applicants.

Estimated Number of Respondents:

12,110. Estimated Number of Responses

Per Respondent: 1. Average Burden

Hours Per Response: .54. Estimated

Total Annual Burden Hours Requested:

6,542. There are no Capital Costs,

Operating Costs, and/or Maintenance

Costs to report.

Type of respondents

Estimated

number of

respondents

Estimate

number of

responses

per respondent

Average

burden

hours per

response

Estimated

total annual

burden

hours requested

Postdoctoral IRTA ............................................................................................................ 600 1 1 600

Predoctoral IRTA .............................................................................................................. 100 1 1 100

Supplemental IRTA .......................................................................................................... 10 1 1 10

Technical IRTA ................................................................................................................. 60 1 1 60

Summer IRTA ................................................................................................................... 3000 1 1 3000

Student Support IRTA ...................................................................................................... 30 1 1 30

References ....................................................................................................................... 8310 .................... .33 2742

Total .................................................................................................................................. 12110 1 .54 6542

REQUEST FOR COMMENTS: Written

comments and/or suggestions from the

public and affected agencies are invited

on one or more of the following points:

(1) Whether the proposed collection of

information is necessary for the proper

performance of the agency, including

whether the information will have

practical utility; (2) The accuracy of the

agency’s estimate of the proposed

collection of information, including the

validity of the methodology and

assumptions used; (3) Ways to enhance

the quality, utility, and the clarity of

information to be collected; and (4)

Ways to minimize the burden of the

collection of information on those who

are to respond, including the use of

appropriate automated, electronic,

mechanical, or other technological

collection techniques or other forms of

information technology.

DIRECT COMMENTS TO: Written comments

and/or suggestions regarding the items

contained in this notice, especially

regarding the estimated public burden

and associated response time, should be

directed to the: Office of Management

and Budget, Office of Regulatory Affairs,

New Executive Office Building, Room

10235, Washington, DC 20503,

Attention: Desk Officer for NIH. To

request more information on the

proposed project or to obtain a copy of

the data collection plans and

instruments, contact: Ms. Yetta L.

Patterson, Personnel Management

Specialist, Office of Human Resource

Management, OD, NIH, Building 31,

Room 1C39, 31 Center Drive MSC 2272,

Bethesda, MD 20892–2272.

COMMENTS DUE DATE: Comments

regarding this information collection are

best assured of having their full effect if

received by April 24, 1997.

Dated: March 18, 1997.

Stephen C. Benowitz,

Director, Office of Human Resource

Management.

[FR Doc. 97–7377 Filed 3–24–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Child Health and

Human Development; Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Child Health and

Human Development Special Emphasis

Panel (SEP) meeting:

Name of SEP: Use of Genetically Modified

Skin to Treat Disease.

Date: April 9–10, 1997.

Time: April 9—7 p.m.—9 p.m.; April 10—

8:30 a.m.—adjournment.

Place: Quality Inn Hotel, 154 West 600

Street, Salt Lake City, Utah 84132.

Contact Person: Gopal Bhatnagar, Ph.D.,

Scientific Review Administrator, NICHD,

6100 Executive Boulevard, 6100 Building,

Room 5E01, Rockville, Maryland 20852,

Telephone: 301–496–1485.

Purpose/Agenda: To evaluate and review

grant applications.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The

discussions of this application could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the applications, the

disclosure of which would constitute a

clearly unwarranted invasion of personal

privacy.

(Catalog of Federal Domestic Assistance

Program Nos. [93.864, Population Research

and No. 93.865, Research for Mothers and

Children, National Institutes of Health)
Federal Register / Vol. 62, No. 57 / Tuesday, March 25, 1997 / Notices 14159

Dated: March 19, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 97–7374 Filed 3–24–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Allergy and

Infectious Diseases; Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meetings.

Name of SEP: Mechanisms of AIDS

Pathogenesis and Novel HIV Vaccine Design

(Telephone Conference Call).

Date: April 2, 1997.

Time: 12 p.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 1A4, Bethesda,

MD 20892, (301) 496–2550.

Contact Person: Dr. Paula Strickland,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., 1A4, Bethesda, MD

20892, (301) 496–2550.

Purpose/Agenda: To evaluate contract

proposals.

Name of SEP: Cost Effectiveness of

Preventing HIV Complications (Telephone

Conference Call).

DATE: April 3, 1997.

TIME: 2 p.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 4C01,

Bethesda, MD 20892, (301) 496–2550.

Contact Person: Dr. Dianne E. Tingley,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C07,

Bethesda, MD 20892, (301) 496–2550.

Purpose/Agenda: To evaluate grant

application.

Name of SEP: Innovative Drug Discovery

Research in AIDS Opportunistic Infections

(Telephone Conference Call).

Date: April 10, 1997.

Time: 12 p.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 1A4, Bethesda,

MD 20892, (301) 496–2550.

Contact Person: Dr. Paula Strickland,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C02,

Bethesda, MD 20892, (301) 402–0643

Purpose/Agenda: To evaluate grant

applications.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than 15

days prior to the above meetings due to the

urgent need to meet timing limitations

imposed by the review and funding cycle.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infections Diseases

Research, National Institutes of Health)

Dated: March 19, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 97–7375 Filed 3–24–97; 8:45 am]

BILLING CODE 4140–01–M

Division of Research Grants; Closed

Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Microbiological and

Immunological Sciences.

Date: April 2, 1997.

Time: 1 p.m.

Place: NIH, Rockledge 2, Room 4178,

Telephone Conference.

Contact Person: Dr. Jean Hickman,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4178, Bethesda,

Maryland 20892, (301) 435–1146.

Name of SEP: Microbiological and

Immunological Sciences.

Date: April 7, 1997.

Time: 1 p.m.

Place: NIH, Rockledge 2, Room 4178,

Telephone Conference.

Contact Person: Dr. Jean Hickman,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4178, Bethesda,

Maryland 20892, (301) 435–1146.

Name of SEP: Behavioral and

Neurosciences.

Date: April 7, 1997.

Time: 2 p.m.

Place: NIH, Rockledge 2, Room 5172,

Telephone Conference.

Contact Person: Dr. Leonard Jakubczak,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5172, Bethesda,

Maryland 20892, (301) 435–1247.

Name of SEP: Biological and Physiological

Sciences.

Date: April 14, 1997.

Time: 1:30 p.m.

Place: NIH, Rockledge 2, Room 5202,

Telephone Conference.

Contact Person: Dr. Anita Sostek, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 5202, Bethesda, Maryland 20892, (301)

435–1260.

Name of SEP: Microbiological and

Immunological Sciences.

Date: April 16, 1997.

Time: 1 p.m.

Place: NIH, Rockledge 2, Room 4178,

Telephone Conference.

Contact Person: Dr. Jean Hickman,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4178, Bethesda,

Maryland 20892, (301) 435–1146.

Name of SEP: Microbiological and

Immunological Sciences.

Date: April 17, 1997.

Time: 1 p.m.

Place: NIH, Rockledge 2, Room 4178,

Telephone Conference.

Contact Person: Dr. Jean Hickman,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4178, Bethesda,

Maryland 20892, (301) 435–1146.

Name of SEP: Biological and Physiological

Sciences.

Date: April 21, 1997.

Time: 10 a.m.

Place: NIH, Rockledge 2, Room 4208,

Telephone Conferences.

Contact Person: Dr. Anita Weinblatt,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4208, Bethesda,

Maryland 20892, (301) 435–1224.

Name of SEP: Biological and Physiological

Sciences.

Date: April 25, 1997.

Time: 10 a.m.

Place: NIH, Rockledge 2, Room 5196,

Telephone Conference.

Contact Person: Ms. Carol Campbell,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5196, Bethesda,

Maryland 20892, (301) 435–1257.

Name of SEP: Biological and Physiological

Sciences.

Date: April 25, 1997.

Time: 3:30 p.m.

Place: NIH, Rockledge 2, Room 4208,

Telephone Conference.

Contact Person: Dr. Anita Weinblatt,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4208, Bethesda,

Maryland 20892, (301) 435–1224.

Name of SEP: Clinical Sciences.

Date: April 30, 1997.

Time: 9 a.m.

Place: NIH, Rockledge, Room 4106,

Telephone Conference.

Contact Person: Ms. Josephine Pelham,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4106, Bethesda,

Maryland 20892, (301) 435–1786.

Purpose/Agenda: To review Small

Business Innovation Research.

Name of SEP: Chemistry and Related

Sciences.

Date: March 27, 1997.

Time: 3 p.m.

Place: NIH, Rockledge 2, Room 5218,

Telephone Conference.

Contact Person: Dr. Marjam Behar,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5218, Bethesda,

Maryland 20892, (301) 435–1180.

Name of SEP: Chemistry and Related

Sciences.

Date: April 2, 1997.

Time: 1 p.m.

Place: NIH, Rockledge 2, Room 5156,

Telephone Conference.

Contact Person: Dr. Chhandra Ganguly,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5156, Bethesda,

Maryland 20892, (301) 435–1739.